ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1138

Comparison of Creatinine-Based Glomerular Filtration Rate Equations for Mortality Prediction in Korean Population: A Retrospective Kangbuk Samsung Health Cohort Study

Session Information

Category: CKD (Non-Dialysis)

  • 2302 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Authors

  • Huh, Daseul, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Korea (the Republic of)
  • Yang, Jihyun, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Korea (the Republic of)
  • Hyun, Young Youl, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Korea (the Republic of)
  • Lee, Kyu-Beck, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Korea (the Republic of)
Background

Several creatinine-based equations have been developed for estimating glomerular filtration rate (GFR). However, their relative performance for mortality prediction in Koreans is unclear, thus the creatinine-based equations have been evolving. We aim to compare the CKD-EPI 2009 and 2021 (race-free) equations to the European Kidney Function Consortium (EKFC) equation for mortality prediction in a large Korean cohort.

Methods

We analyzed 670,320 participants who underwent a comprehensive health examination, enrolled in Kangbuk Samsung Health Cohort from January 1, 2002 to December 31, 2019 and followed them up for mortality until December 2019.

Results

The participants’ median follow-up period was 8.8 years, mean age was 39.8 years old (minimum 18, maximum 97), and 53.6% were male. Mean eGFR using 2009 CKD-EPI was 95.1 ml/min/1.73m2, 100.6 ml/min/1.73m2 using 2021 CKD-EPI, 94.0 ml/min/1.73m2 using EKFC. The EKFC equation had the highest discriminatory power to predict all-cause mortality (Harrell’s C index of EKFC = 0.694 (95% confidence interval 0.687-00.701), 2021 CKD-EPI = 0.665 (95% CI 0.659-0.672), 2009 CKD-EPI = 0.667 (0.636-0.648), p < 0.001) and cardiovascular disease (CVD) mortality (Harrell’s C index of EKFC = 0.745 (95% CI 0.728-0.762), 2021 CKD-EPI = 0.716 (95% CI 0.699-0.732), 2009 CKD-EPI = 0.716 (95% CI 0.699-0.732)).

Conclusion

In this large cohort of Koreans, the EKFC equation showed superior discrimination for predicting all-cause and CVD morality versus CKD-EPI equations. These findings support the adoption of the EKFC equation for GFR estimation and mortality risk prediction in this population.